In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

2009's Top Biopharma Dealmakers

Executive Summary

A flurry of dealmaking in December, especially by big pharmacos, helped to bring 2009 to a strong close in terms of alliances. But the year will probably most be remembered for the Big Pharma mega mergers that combined four major companies and topped the acquisitions list by their dollar values. We focus here on the dealmakers, showing which companies dominated the dealmaking landscape in terms of deal volume and value, as well as therapeutic categories that grabbed the most attention.
Advertisement

Related Content

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2009
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2009
Biopharma Trends: Nowhere To Go But Up

Topics

Advertisement
UsernamePublicRestriction

Register

IV003385

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel